Vestal Point Capital’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13M | Buy |
3,228,161
+2,091,912
| +184% | +$8.41M | 0.68% | 42 |
|
|
2025
Q1 | $3.94M | Sell |
1,136,249
-63,751
| -5% | -$221K | 0.28% | 47 |
|
|
2024
Q4 | $7.9M | Buy |
1,200,000
+350,000
| +41% | +$2.3M | 0.47% | 46 |
|
|
2024
Q3 | $7.68M | Buy |
850,000
+10,000
| +1% | +$90.4K | 0.58% | 38 |
|
|
2024
Q2 | $13.5M | Buy |
840,000
+665,000
| +380% | +$10.7M | 1% | 30 |
|
|
2024
Q1 | $2.74M | Buy |
+175,000
| New | +$2.74M | 0.23% | 49 |
|